Charlotte's Web Holdings, Inc.

CWBHF

OTC

Healthcare

Drug Manufacturers - Specialty & Generic

Louisville, CO, US112 employeescharlottesweb.com

—

At a Glance

AI-generated

Revenue remained nearly flat at $49.9M amid CBD headwinds, but gross profit and operating loss improvements reflect cost discipline and absence of prior-year inventory provisions, narrowing losses despite ongoing cash burn.

Revenue breakdown: Product (99%), Service (1%).

8-K

Charlotte's Web entered a subscription agreement with BAT for a US$10 million equity investment and amended a convertible debenture, resulting in BAT holding approximately 40.8% ownership post-transaction.

—

Market Cap

—

Revenue

—

Net Income

Employees112

Fundamentals

How The Business Makes Money

Revenue by Segment

Product99%($99M)

Service1%($948.0K)

Activity

What Changed Recently

Material Agreement

Mar 31, 2026

. Entry Into a Material Definitive Agreement. On November 14, 2022, Charlotte's Web Holdings, Inc. (the "Company"), entered into a subscription agreement with B

Financial Results

Mar 30, 2026

by reference. Item 9.01. Financial Statements and Exhibits. ( d) Exhibits Additional Information and Where to Find It In connection with the proposed transactio

Other Event

Mar 30, 2026

Other Matters.. On March 30, 2026, Charlotte’s Web Holdings, Inc. (the “Company”) issued a press release announcing the entry into a transaction with BT DE Inve

Peer Companies

Company	Price	Change	Market Cap	P/E
FNCHFinch Therapeutics Group,...	—	—	—	—
EOFBFEcofibre Limited	—	—	—	—
ROMJFRubicon Organics Inc.	—	—	—	—
ISCNFIsracann Biosciences Inc.	—	—	—	—
VYYRFVoyageur Pharmaceuticals ...	—	—	—	—
CNTMFFluent Corp.	—	—	—	—
AVCNFAvicanna Inc.	—	—	—	—
MEDIFMediPharm Labs Corp.	—	—	—	—

Analyst View

Company Profile

CIK0001750155

ISINCA16106R1091

CUSIP16106R109

Phone720 617 7303

Address1801 California Street, Louisville, CO, 80202, US

SEC EDGAR